Vascular Surgeon (Endovascular Surgeon) Specialist Dato' Dr Ho Teik Kok

Dato' Dr Ho Teik Kok

23 Years Experience Verified
Video
       
In Person

About Doctor

Dato' Dr Ho Teik Kok, Consultant Vascular / Endovascular & General Surgeon, completed the Bachelor of Medicine, Bachelor of Surgery degree at the Universit ... See More

Practices

Specialization

Vascular Surgeon (Endovascular Surgeon)
General Surgeon

Qualifications

MBBS (UM), MRCS (Edinburgh), MRCS (England), Intercollegiate FRCS General & Vascular Surgery (UK), Certificate of Completion of Training (UK), PhD in Vascular Surgery (UK)

Awards & Recognition

【PUBLISHED ABSTRACTS】 • M Salji, P Gogalniceanu, TK Ho, S Mackenzie, P Patient, S Choksy, C Backhouse, R Motson, A Howard; Comparison of operative outcomes of laparoscopic versus open repair of abdominal aortic aneurysms – A prospective study of a single centre learning experience. International Journal of Surgery 2012; 10(8):S109 • T. K. Ho, S. Xu, D. Joshi, J. Tsui, D. J. Abraham,D. M. Baker. CXCL12 upregulated by hypoxia and stimulates cell proliferation via P44/42 and attenuates apoptosis via PI3/AKT pathways in angiogenesis. British Journal of Surgery 97(S6) 13-14 Nov 2010 • Dhiraj Joshi, T. K. Ho, Janice Tsui, S. Selvakumar, Korsa Khan, David Abraham, Daryll Baker. Erythropoietin is angiogenic and tissue protective in human critical limb ischaemia. British Journal of Surgery 97(S6) 13-14 Nov 2010 • T. K. Ho The Angiogenic Effects of CXCL12 Variants and the Expressions of CXCL12 Variants and CXCR4 in Human Critical Limb Ischaemia. Cardiovascular Pathology; Vol 17(4) Page 268; July/August 2008 • T. K. Ho, S. Xu, P. Leoni, N. Aden, C. DiSalvo, R.Walesby, C.M. Black, D.J. Abraham, G. Hamilton, D.M. Baker. Increased SDF-1alpha and CXCR4 but not SDF-1beta expression in human critical limb ischaemia. British Journal of Surgery; Vol 95(4) S1:3; February 2008 • T. K. Ho, M. Griffiths, M. Dashwood, R. Stratton, C. M. Black, D.J. Abraham, G. Hamilton and D.M. Baker. Endothelin-1 promotes proliferation and angiogenesis via the ETB receptor. British Journal of Surgery; Vol 94 S1:2; February 2007 • T.K. Ho, M. Griffiths, R. Stratton, C.M. Black, D.J. Abraham and D.M. Baker. Endothelin-1 promotes proliferation and angiogenesis in cultured endothelial cells via the ETB receptor Vascular Pharmacology; Vol 45(3) Page e114 September 2006 • T.K. Ho, X. Shiwen, C. DiSalvo, R.K. Walesby, C.M. Black, D.J. Abraham and D.M. Baker. Angiogenic roles of stromal-derived factor-1(SDF-1/CXCL12) variants and in-vivo CXCR4 expression in microvessels of human critical limb ischaemia. Vascular Pharmacology; Vol 45(3) Page e116; September 2006 • T.K. Ho, V. Rajkumar, K. Khan, C. DiSalvo, R.K. Walesby, C.M. Black, D.J. Abraham and D.M. Baker. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in human critical limb ischaemia. Vascular Pharmacology; Vol 45(3) Page e118; September 2006 • TK Ho, S Xu, DJ Abraham, CM Black, DM Baker. Angiogenic roles of the chemokine stromal-derived factor-1(SDF-1/CXCL12) variants and involvement of AKT and ERK1/2 signalling pathways in human microvascular endothelial cells. British Journal of Surgery Vol 9(7):896-902 July 2006 • TK Ho, V Rajkumar, M Ponticos, M Garcia, K Khan, C Hart, DiSalvo, RK Walesby, DJ Abraham, CM Black, DM Baker. Increased hypoxia inducible factor-1alpha and localisation of erythropoietin in human critical limb ischaemia. British Journal of Surgery Vol 9(7):896-902 July 2006 • TK Ho, V Rajkumar, M Ponticos, M Garcia, K Khan, C Hart, DiSalvo, RK Walesby, DJ Abraham, CM Black, DM Baker. Increased hypoxia inducible factor-1alpha and localisation of erythropoietin in human critical limb ischaemia British Journal of Surgery Vol 93 (S2):21 April 2006 • TK Ho, S Xu, DJ Abraham, CM Black, DM Baker. The chemokine stromal-derived factor-1 (SDF-1/CXCL12) beta is the more potent variant in human microvascular cell survival and proliferation. British Journal of Surgery Vol 93 (S2):8 April 2006 • TK Ho, DJ Abraham, CM Black, V Rajkumar, C DiSalvo, RK Walesby, C Hart, DM Baker, Increased hypoxia inducible factor – 1alpha expression and angiogenesis in critical limb ischaemia in human. British Journal of Surgery Vol 92 (S1):81 April 2005 【ORAL PRESENTATIONS】 • A Dedicated Multidisciplinary Amputee Service Achieves Improved Patient Experience and Reduces Length of Stay. The Vascular Society of Great Britain and Ireland (VSGBI) Annual Meeting, Edinburgh, November 2011 • CXCL12 Upregulated By Hypoxia And Stimulates Cell Proliferation Via p44/42 And Attenuates Apoptosis Via PI3/Akt Pathways In Angiogenesis, Society of Academic and Research Surgery (SARS) Annual Meeting, London, January 2010 • The Angiogenic Effects of CXCL12Variants and the Expressions of CXCL12 Variants and CXCR4 in Human Critical Limb Ischaemia, International Society of Applied Cardiovascular Biology (ISCAB) Biennial Meeting, Bordeaux, September 2008 – Young Investigator Award Winner • Increased SDF-1alpha and CXCR4 but not SDF-1beta expression in human critical limb ischaemia, SARS Annual Meeting, Birmingham, January 2008 • Stromal-derived factor (SDF)-1 in Human Critical Limb Ischaemia, The Vascular Society of Great Britain and Ireland (VSGBI) Annual Meeting, Manchester, November 2007 – Prize Winner of SARS Session • Increased SDF-1alpha But Not SDF-1beta Expression With Raised CXCR4 In Human Critical Limb Ischemia, Society of Vascular Surgery (SVS) Research Initiatives Conference, Washington DC, March 2007 • Endothelin-1 promotes proliferation and angiogenesis via the ETB receptor, The Vascular Society of Great Britain and Ireland (VSGBI) Annual Meeting, Edinburgh, November 2006 • Angiogenic Effects Of Stromal-derived Factor-1(SDF-1/CXCL12) Variants And In-vivo Microvessel Expression Of CXCR4 In Human Critical Limb Ischemia; Society of Vascular Surgery (SVS) Research Initiatives Conference, Washington DC, March 2006 • Patey Prize Session: Increased Hypoxia Inducible Factor – 1 And Localisation Of Erythropoietin In Human Critical Limb Ischaemia, Society of Academic and Research Surgery (SARS) Meeting, Edinburgh, January 2006 • Patey Prize Session: Angiogenic Roles Of The Chemokine Stromal-Derived Factor-1 (SDF-1/CXCL12) Variants And Involvement Of Akt And Erk 1/2 Signalling Pathways In Human Microvascular Endothelial Cells, Society of Academic and Research Surgery (SARS) Meeting, Edinburgh, January 2006 • BJS Prize Session: Increased HIF-1alpha and Localisation of Erythropoietin In Human Critical Limb Ischaemia, The Vascular Society of Great Britain and Ireland (VSGBI) Annual Meeting, Bournemouth, November 2005 • The Chemokine SDF-1(CXCL12)-beta is The More Potent Variant In Human Microvascular Cell Survival and Proliferation, VSGBI Annual Meeting, Bournemouth, November 2005 • International Union of Angiology Prize Session: Angiogenesis and Characterisation of Vascular Endothelial Subtypes in Human Critical Limb Ischaemia, EUROCHAP, Glasgow, October 2005 • Increased Angiogenic Response and HIF-1alpha in Human Critical Limb Ischaemia; Society of Vascular Surgery (SVS) Annual Meeting, Chicago, USA, June 2005 【POSTERS】 • Endothelin-1 promotes proliferation and angiogenesis in cultured endothelial cells via the ETB receptor; International Vascular Biology Meeting (IVBM), Noordwijkerhout, The Netherlands, June 2006 • Increased Angiogenic Response But Deficient Arteriolization And Abnormal Microvessel Ultrastructure In Human Critical Limb Ischaemia; IVBM, Noordwijkerhout, The Netherlands, June 2006 • Angiogenic Roles Of Stromal-Derived Factor-1(SDF-1/CXCL12) Variants and In-vivo CXCR4 Expression in Microvessels of Human Critical Limb Ischaemia; IVBM, Noordwijkerhout, The Netherlands, June 2006 • Endothelin-1 Promotes Proliferation and Angiogenesis in Cultured Endothelial Cells via The ETB Receptor, SVS Research Initiatives Conference, Washington DC, March 2006 • Increased HIF-1alpha and Angiogenic Response In Critical Limb Ischaemia In Human; Association of Surgeons of Great Britain & Ireland (ASGBI) Annual Meeting, Glasgow, April 2005 • Endogenous Angiogenic Response In Human Critical Limb Ischaemia; Association of Surgeons in Training (ASiT) Annual Meeting, Sheffield March 2005 • Unscheduled Re-Attendence In The A&E Department; British Association for Emergency Medicine (BAEM) Conference, April 2003ON

Medical Registry

Malaysia Medical Council: 57004
National Specialist Register: 129520

Languages

English
Bahasa Malaysia
Mandarin

Conditions Consulted


Services Consulted

Get more from DoctorOnCall

What do people say about DoctorOnCall

Nabilah Eddie
5
The doctor is fast respon. Totally professional. Feeling consulting a doctor face to face where you can talk to the doctor how you feel and the doctor will give you the right medic ... See More
Ramanathan Alaganchetty
5
Excellent service
Fatin Syahirah
5
I'm very happy using their service. I bought 4 boxes of Akurit 4 and get RM40 discount. …MoreI'm very happy using their service. I bought 4 boxes of Akurit 4 and get RM40 discount. ... See More
See All Reviews
  • Step 1: Choose Consultation Type
    Choose from below list
    Video
    In Person
  • Step 2: Choose Date & Time
    Choose date and time from available slots
Morning
0.00
0.30
1.00
1.30
2.00
2.30
3.00
3.30
4.00
4.30
5.00
5.30
6.00
6.30
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
Afternoon
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
20.00
20.30
21.00
21.30
22.00
22.30
23.00
23.30
Your booking is being processed. Please do not close this window.
Close




Please check the appointment summary and click on 'Continue'.

Vascular Surgeon (Endovascular Surgeon) Specialist Dato' Dr Ho Teik Kok
Dato' Dr Ho Teik Kok
Vascular Surgeon (Endovascular Surgeon)

Continue
Updated on: 3/5/2021
Disclaimer: All information about the Medical professionals (e.g. description of services / specialisations, years in practice, recognitions / awards, education, etc) displayed on the Website and/or App are posted by the respective Medical professionals and/or based on information supplied by the respective Medical professionals to DoctorOnCall. The respective Medical professionals are solely responsible for the authenticity and accuracy of such information about themselves on the Website and/or App and DoctorOnCall is and will not be responsible for any losses or damages caused by, whether directly or indirectly, any User’s reliance on such information.
Need Help?
Enquire Online
Please select the most convenient way for us to connect with you
Get support in WhatsApp Get support in Messenger